OptimizeRx
Watchlist
OptimizeRx Corp. (OPRX): Surprising Profitability Development and Revenue Forecast Increase - Analyst Raises Target Price to $22!

Reading Time: 2 minutes
OptimizeRx Corp. (OPRX) is a leading provider of digital communication solutions for the healthcare industry. The company released a strong report for the first quarter after the market closed on May 12. According to the report, revenue increased by 11% year-over-year to $21.39 million, and EPS improved from -$0.11 to $0.08. The company's liquidity situation also improved, with cash reserves of $16.6 million at the end of the quarter. Gross profit also rose to $13.3 million, representing a 9% increase compared to the first quarter of 2024. Analysts...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.